Key result
Aortic stenosis and hypertension commonly coexist, and ACE-inhibitors are the most well-studied antihypertensive agents for treating hypertension in patients with severe aortic stenosis.
This review highlights the pathophysiological challenges of managing coexisting hypertension and aortic stenosis, noting that ACE-inhibitors are currently the most well-studied medical therapy in this context.
ACE-inhibitors may warrant consideration in coexisting severe aortic stenosis and hypertension; leaves open need for randomized trials.
BACKGROUND: Aortic stenosis is a common form of valvular heart disease which often coexists with hypertension. These diseases represent two distinct forms of left ventricular systolic overload and in combination may be associated with disadvantageous left ventricular remodeling, increased mortality and heart failure. The treatment of hypertension in aortic stenosis remains a challenging problem with limited data to guide clinical practice. METHODS: We performed a comprehensive online literature review to find relevant published literature on the topic of hypertension and aortic stenosis. RESULTS: In the present manuscript, we review the pathophysiology of aortic stenosis in combination with hypertension and the effects on the left ventricle. We also provide general recommendations for medical therapy for treatment of hypertension in aortic stenosis and review the available data on specific antihypertensive agents in this context. CONCLUSIONS: Aortic stenosis and hypertension commonly coexist and significantly impact the diagnosis and classification of aortic stenosis severity and symptoms. Treatment of hypertension among patients with severe aortic stenosis can be challenging. Among specific antihypertensive agents studied in this context, ACE-inhibitors are the most well studied.
No takes yet. Share an insight, caveat, or question.
Rassa et al. (2018) conducted a review in Aortic stenosis and hypertension. Antihypertensive agents (ACE-inhibitors) was evaluated. Aortic stenosis and hypertension commonly coexist, and ACE-inhibitors are the most well-studied antihypertensive agents for treating hypertension in patients with severe aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: